A Double-Blind Placebo-Controlled Comparison of a Novel Formulation of Intravenous Diclofenac and Ketorolac for Postoperative Third Molar Extraction Pain

Dyloject is a novel formulation of diclofenac intended for intravenous (IV) administration. This formulation employs the solubilizing agent hydroxypropyl-β-cyclodextrin to permit bolus IV administration. The efficacy and safety of 5 dose levels of IV diclofenac were compared with IV ketorolac and pl...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Christensen, Kyle, Daniels, Stephen, Bandy, Donald, Ernst, Cynthia C., Hamilton, Douglas A., Mermelstein, Fred H., Wang, Jianyuan, Carr, Daniel B.
Formato: Artigo
Idioma:Inglês
Publicado: American Dental Society of Anesthesiology 2011
Assuntos:
Scientific Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3198130/
https://ncbi.nlm.nih.gov/pubmed/21679043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2344/0003-3006-58.2.73
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares